Lallemand launches immunity blend
EFSA has approved general function, inflammation, immunity and antioxidant article 13 claims for selenium and vitamin D, and while these have yet to enter European Union law books, the company is highlighting the EFSA positive opinions.
It will give the blend – Lalmin Immune – an official launch at the Vitafoods Europe trade show in Geneva next week.
“This formula has been settled taking into account recommended daily allowances from Europe, US and Asia for Selenium and Vitamin D,” product manager in mineral and vitamin enriched yeasts, Morgane Maillard, told NutraIngredients.
“Yeast glucan concentration has been settled taking into account the amount required for an effective action in the human body.”
The company said 350mg of Lalmin Immune delivered 100 per cent of an average of recommended daily intakes for selenium and vitamin D in Europe, the US and Asia, but the blend could be tailored to fit.
“Specific recipes of this product can be created according to market needs – for example European version with 55µg of selenium (100% European RDA for selenium) and 5µg of Vitamin D (100% European RDA for Vitamin D).”
She noted EFSA-approved claims came with conditions of use that stipulated at least 15% of the RDA must be present to bear claims, that are set for European Commission and member state consideration and likely approval in early 2012.
The approved claims include:
- “Selenium contributes to the normal function of the immune system”
- “Seleniumcontributes to the protection of cell constituents from oxidative damage”
- “Vitamin D contributes to the normal function of the immune system and healthy inflammatory response”
